IGP — Imperial Ginseng Products Income Statement
0.000.00%
Consumer DefensivesSpeculativeMicro Cap
Annual income statement for Imperial Ginseng Products, fiscal year end - June 30th, CAD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 7.2 | 3.44 | 4.3 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | 0.179 | -0.206 | 0.051 | 0 | — |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 9.12 | 6.49 | 6.4 | 0.722 | 0.196 |
| Operating Profit | -1.93 | -3.05 | -2.1 | -0.722 | -0.196 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -5.71 | 2.98 | 4.03 | 0.281 | -0.189 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -4.48 | 2.32 | 2.92 | 0.208 | -0.174 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -4.48 | 2.32 | 2.92 | 0.208 | -0.174 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -4.48 | 2.32 | 2.92 | 0.208 | -0.174 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.204 | 0.385 | 0.034 | -0.014 | -0.023 |
| Special Dividends per Share |